Altre lingue K2X Technology & Life Science, Inc.

Azioni

KBPH

US5015722003

Mercato chiuso - OTC Markets Altri mercati azionari 21:30:56 22/08/2022			Variaz. 5gg	Var. 1 gen.
1 ^USD	-45,65%		-.--%	-.--%

2022	Kyto Technology and Life Science, Inc. riporta i risultati degli utili per il terzo trimestre e i nove mesi conclusisi il 31 dicembre 2021	CI
2021	Kyto Technology and Life Science, Inc. riporta i risultati degli utili per il secondo trimestre e i sei mesi conclusi il 30 settembre 2021	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

FluidAI Medical announced that it has received CAD 15 million in funding from a group of investors	10/10/23
Infinidome Ltd. announced that it has received $9 million in funding from Hanwha Aerospace Co., Ltd., Next Gear Ventures, Honeywell Ventures, VentureIsrael, Kyto Technology and Life Science, Inc., Aston Capital Management and another investor	24/04/23
Mrinq Technologies LLP announced that it has received $2.5 million in funding from a group of investors	10/11/22
KYTO TECHNOLOGY & LIFE SCIENCE, INC. : Other Events, Financial Statements and Exhibits (form 8-K)	09/05/22
Kyto Technology & Life Science Inc. Announces the Termination of Tender Offer	07/05/22
Kyto Technology & Life Science Inc. Announces the Termination of Tender Offer	07/05/22
KYTO TECHNOLOGY & LIFE SCIENCE, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITIONS AND RESULTS OF OPERATIONS (form 10-Q)	22/02/22
Kyto Technology and Life Science, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021	22/02/22
KYTO TECHNOLOGY & LIFE SCIENCE, INC. : Unregistered Sale of Equity Securities (form 8-K)	09/02/22
Kyto Technology and Life Science, Inc. announced that it has received $2.620875 million in funding	04/02/22
Rhaeos, Inc. announced that it has received $2.2 million in funding from a group of investors	23/12/21
KYTO TECHNOLOGY & LIFE SCIENCE, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITIONS AND RESULTS OF OPERATIONS (form 10-Q)	18/11/21
Kyto Technology and Life Science, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2021	18/11/21
KYTO TECHNOLOGY & LIFE SCIENCE, INC. : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	10/11/21
KYTO TECHNOLOGY & LIFE SCIENCE, INC. : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)	12/10/21
Kyto Technology and Life Science : & LIFE SCIENCE, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITIONS AND RESULTS OF OPERATIONS (form 10-Q/A)	06/10/21
Kyto Technology and Life Science : & LIFE SCIENCE, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITIONS AND RESULTS OF OPERATIONS (form 10-Q)	01/10/21
Kyto Technology and Life Science, Inc. Reports Earnings Results for the First Quarter Ended June 30, 2021	01/10/21
KYTO TECHNOLOGY & LIFE SCIENCE, INC. : Unregistered Sale of Equity Securities (form 8-K)	08/09/21
Kyto Technology and Life Science, Inc. announced that it has received $0.21 million in funding	01/09/21

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue K2X Technology & Life Science, Inc.

Azioni

KBPH

US5015722003

Altre lingue

Filtri